Timepoint | Study Period | |||
---|---|---|---|---|
Enrolment | Inital assessment | Follow-up at 3 months | Follow-up at 6 months | |
Enrolment | ||||
Eligibility screen | X | |||
Information to patients/careviger | X | |||
Collection of consent | X | |||
Date of the visits | X | X | X | X |
Assessments | ||||
Primary outcome: | ||||
Unplanned Hospitalizations | X | |||
Secondary outcomes: | ||||
Unplanned Hospitalizations | X | |||
Behavioral disorders (NPI) | X | X | X | |
Quality of life (EQ-5D-3 L) | X | X | X | |
Number of falls | X | X | X | |
Number of patients with at least 1 potentially inappropriate prescription | X | X | X | |
Nursing staff satisfaction | X | X | ||
Characteristics of patients whose GP have taken account of TMR recommendations | X | X | ||
GP’ adherence rate to therapeutic recommendations | X | X | ||
Cost-effectiveness ratio of TMR | X | |||
Factors facilitating or hampering GPs’ adherence rate | X | X | X | |
Characteristics | ||||
Sociodemographic data (age, gender) | X | X | ||
MMSE | X | |||
Comorbidities | X | X | X | |
Pharmaceutical therapeutics | X | X | X | |
Blood test | X | X | X | |
Trivalle’s score | X |